Globe Newswire LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) ( Mereo or the Company ), a clinical-stage biopharmaceutical company focused on rare diseases, today announced...\n more…
Ticker Report Biohaven (NYSE:BHVN - Get Free Report) and Mereo BioPharma Group (NASDAQ:MREO - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses...\n more…
Ticker Report Mereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) Director Deepika Pakianathan sold 105,244 shares of the stock in a transaction that occurred on Thursday, August 22nd. The shares were sold...\n more…
Ticker Report Shares of Mereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) were up 5.8% during mid-day trading on Friday . The company traded as high as $4.84 and last traded at $4.77. Approximately 231,595...\n more…
Ticker Report Mereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) reached a new 52-week high on Thursday . The stock traded as high as $4.55 and last traded at $4.51, with a volume of 20560 shares changing...\n more…
Ticker Report Mereo BioPharma Group plc (NASDAQ:MREO - Get Free Report)'s stock price was down 2.8% during trading on Thursday . The stock traded as low as $3.81 and last traded at $3.84. Approximately 128,809...\n more…